Alexander Vos
Independent DirectorMr. Alexander Vos, M.B.A., is Chairman of the Board of Scenic Biotech B.V. He served as Director of Alpha Teknova, Inc. He is Non-Executive Director of RoslinCT from June 2024. He serves as a Venture Partner at BioGeneration Ventures B.V. since July 2019. He served as the Chief Executive Officer at VectorY Therapeutics BV since June 2021 until November 2022 and also serves as its Member of Supervisory Board. Mr. Vos held senior positions at multiple private and public biopharma companies, such as Genzyme (Europe) and Paion AG. From October 2018 until May 2021, he served as Chief Executive Officer of VarmX BV. From September 2018 until May 2021, Mr. Vos served as Chairman of the board of directors of Symeres BV (formerly Mercachem-Syncom). Initially, he spent five years at the pharmaceutical practice of McKinsey & Co. and then continued at Genzyme Therapeutics Europe, holding several executive positions, including global responsibility for the Genzyme/Pharming JV to develop an ERT for Pompe’s Disease. From 2000 to 2004, he served as CEO of MediService AG (Switzerland), one of the leading specialty pharmacy service companies in Europe, which was successfully sold to Galenica AG. He joined PAION AG, a publicly listed, clinical stage biopharma company based in Aachen (Germany) as a Member of the Management Board (“Vorstand”), deputy-CEO and COO. In 2010, he became the CEO of PharmaCell BV and helped turn it into the leading European CMO for cell and gene therapy. He has been one of the industry pioneers laying the foundation in Europe for the global industry group Alliance for Regenerative Medicine and subsequently served on the executive board. He serves as member of the supervisory board of CiMaas BV, a company focused on developing cellular immunotherapy for specific oncology indications, since September 2018. Mr. Alexander Vos holds a MS in Pharmacy and Pharmacology from the University of Amsterdam and an MBA from Stanford University.
Positions
- Company NameAlpha Teknova, Inc.Stock CodeTKNOPositionIndependent DirectorColleagues
- SGStephen GunstreamPresident, CEO & Director
- PDPaul D. GrossmanChairman of the Board
- MCMatthew C. LowellChief Financial Officer
- DADamon A. TerrillGeneral Counsel, Chief Compliance Officer & Secretary
- JHJennifer HenrySenior Vice President of Marketing
- BMBrett M. RobertsonIndependent Director
- MJMartha J. DemskiIndependent Director
